Skip to main content

Table 2 Treatment adjustments at each time point

From: Type 2 diabetes progression in an adult Ugandan population with new-onset diabetes: an observational prospective study

Time point

Treatment adjustment

Metformin only (n,%)

Metformin and sulfonylurea (n,%)

3 months (n = 131 participants)

-New drug added and/or the dose of > 1 drug increased

16, 35.6%

8, 10.7%

6 months (n = 92 participants)

-New drug added and/or the dose of > 1 drug increased

10, 40%

10, 16.7%

9 months (n = 67 participants)

-New drug added and/or the dose of > 1 drug increased

12, 50%

7, 21.2%

12 months (n = 116 participants)

-New drug added and/or the dose of > 1 drug increased

17, 39.5%

17, 27.9%